Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

被引：284

作者：

Na, Rong ^{[1
,2
]}

Zheng, S. Lilly ^{[2
,3
]}

Han, Misop ^{[4
,5
]}

Yu, Hongjie ^{[2
,6
]}

Jiang, Deke ^{[2
,6
]}

Shah, Sameep ^{[2
]}

Ewing, Charles M. ^{[4
,5
]}

Zhang, Liti ^{[4
,5
]}

Novakovic, Kristian ^{[2
,3
]}

Petkewicz, Jacqueline ^{[2
,3
]}

Gulukota, Kamalakar ^{[8
]}

Helseth, Donald L., Jr. ^{[8
]}

Quinn, Margo ^{[2
,3
]}

Humphries, Elizabeth ^{[4
,5
]}

Wiley, Kathleen E. ^{[4
,5
,9
]}

Isaacs, Sarah D. ^{[4
,5
]}

Wu, Yishuo ^{[1
]}

Liu, Xu ^{[2
,6
]}

Zhang, Ning ^{[1
,2
]}

Wang, Chi-Hsiung ^{[2
]}

Khandekar, Janardan ^{[8
]}

Hulick, Peter J. ^{[7
]}

Shevrin, Daniel H.

Cooney, Kathleen A.

Shen, Zhoujun ^{[1
]}

Partin, Alan W. ^{[4
,5
]}

Carter, H. Ballentine ^{[4
,5
]}

Carducci, Michael A. ^{[10
]}

Eisenberger, Mario A. ^{[10
]}

Denmeade, Sam R. ^{[10
]}

McGuire, Michael ^{[3
]}

Walsh, Patrick C.

Helfand, Brian T. ^{[2
,3
]}

Brendler, Charles B. ^{[2
,3
]}

Ding, Qiang ^{[1
]}

Xu, Jianfeng ^{[1
,2
,3
,6
]}

Isaacs, William B. ^{[4
,5
,10
]}

机构：

[1] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai, Peoples R China

[2] Program Isaacs Personalized Canc Care, Evanston, IL USA

[3] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA

[4] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Baltimore, MD USA

[6] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China

[7] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA

[8] NorthShore Univ HealthSyst, Dept Ctr Mol Med, Evanston, IL USA

[9] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA

[10] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA

来源：

EUROPEAN UROLOGY | 2017年 / 71卷 / 05期

基金：

中国国家自然科学基金;

关键词：

Lethal prostate cancer; Germline; Mutation; DNA repair genes; CARRIERS; GENE; MEN; SUSCEPTIBILITY; PROGRESSION; SURVIVAL;

D O I：

10.1016/j.eururo.2016.11.033

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Germline mutations in BRCA1/2 and ATM have been associated with prostate cancer (PCa) risk. Objective: To directly assess whether germline mutations in these three genes distinguish lethal from indolent PCa and whether they confer any effect on age at death. Design, setting, and participants: A retrospective case-case study of 313 patients who died of PCa and 486 patients with low-risk localized PCa of European, African, and Chinese descent. Germline DNA of each of the 799 patients was sequenced for these three genes. Outcome measurements and statistical analysis: Mutation carrier rates and their effect on lethal PCa were analyzed using the Fisher's exact test and Cox regression analysis, respectively. Results and limitations: The combined BRCA1/2 and ATM mutation carrier rate was significantly higher in lethal PCa patients (6.07%) than localized PCa patients (1.44%), p = 0.0007. The rate also differed significantly among lethal PCa patients as a function of age at death (10.00%, 9.08%, 8.33%, 4.94%, and 2.97% in patients who died <= 60 yr, 61-65 yr, 66-70 yr, 71-75 yr, and over 75 yr, respectively, p = 0.046) and time to death after diagnosis (12.26%, 4.76%, and 0.98% in patients who died <= 5 yr, 6-10 yr, and > 10 yr after a PCa diagnosis, respectively, p = 0.0006). Survival analysis in the entire cohort revealed mutation carriers remained an independent predictor of lethal PCa after adjusting for race and age, prostate-specific antigen, and Gleason score at the time of diagnosis (hazard ratio = 2.13, 95% confidence interval: 1.24-3.66, p = 0.004). A limitation of this study is that other DNA repair genes were not analyzed. Conclusions: Mutation status of BRCA1/2 and ATM distinguishes risk for lethal and indolent PCa and is associated with earlier age at death and shorter survival time. Patient summary: Prostate cancer patients with inherited mutations in BRCA1/2 and ATM are more likely to die of prostate cancer and do so at an earlier age. (C) 2016 European Association of Urology. Published by Elsevier B. V. All rights reserved.

引用

页码：740 / 747

页数：8

共 32 条

[1] Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer [J].

Agalliu, Ilir ;

Kwon, Erika M. ;

Zadory, Daniel ;

McIntosh, Laura ;

Thompson, Joseph ;

Stanford, Janet L. ;

Ostrander, Elaine A. .

CLINICAL CANCER RESEARCH, 2007, 13 (03) :839-843

[2] The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer [J].

Akbari, M. R. ;

Wallis, C. J. D. ;

Toi, A. ;

Trachtenberg, J. ;

Sun, P. ;

Narod, S. A. ;

Nam, R. K. .

BRITISH JOURNAL OF CANCER, 2014, 111 (06) :1238-1240

[3] A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer [J].

Al Olama, Ali Amin ;

Kote-Jarai, Zsofia ;

Berndt, Sonja I. ;

Conti, David V. ;

Schumacher, Fredrick ;

Han, Ying ;

Benlloch, Sara ;

Hazelett, Dennis J. ;

Wang, Zhaoming ;

Saunders, Ed ;

Leongamornlert, Daniel ;

Lindstrom, Sara ;

Jugurnauth-Little, Sara ;

Dadaev, Tokhir ;

Tymrakiewicz, Malgorzata ;

Stram, Daniel O. ;

Rand, Kristin ;

Wan, Peggy ;

Stram, Alex ;

Sheng, Xin ;

Pooler, Loreall C. ;

Park, Karen ;

Xia, Lucy ;

Tyrer, Jonathan ;

Kolonel, Laurence N. ;

Le Marchand, Loic ;

Hoover, Robert N. ;

Machiela, Mitchell J. ;

Yeager, Merideth ;

Burdette, Laurie ;

Chung, Charles C. ;

Hutchinson, Amy ;

Yu, Kai ;

Goh, Chee ;

Ahmed, Mahbubl ;

Govindasami, Koveela ;

Guy, Michelle ;

Tammela, Teuvo L. J. ;

Auvinen, Anssi ;

Wahlfors, Tlina ;

Schleutker, Johanna ;

Visakorpi, Tapio ;

Leinonen, Katri A. ;

Xu, Jianfeng ;

Aly, Markus ;

Donovan, Jenny ;

Travis, Ruth C. ;

Key, Tim J. ;

Siddiq, Afshan ;

Canzian, Federico .

NATURE GENETICS, 2014, 46 (10) :1103-1109

[4]

Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310

[5] Prostate Cancer Early Detection, Version 2.2016 [J].

Carroll, Peter R. ;

Parsons, J. Kellogg ;

Andriole, Gerald ;

Bahnson, Robert R. ;

Castle, Erik P. ;

Catalona, William J. ;

Dahl, Douglas M. ;

Davis, John W. ;

Epstein, Jonathan I. ;

Etzioni, Ruth B. ;

Farrington, Thomas ;

Hemstreet, George P., III ;

Kawachi, Mark H. ;

Kim, Simon ;

Lange, Paul H. ;

Loughlin, Kevin R. ;

Lowrance, William ;

Maroni, Paul ;

Mohler, James ;

Morgan, Todd M. ;

Moses, Kelvin A. ;

Nadler, Robert B. ;

Poch, Michael ;

Scales, Chuck ;

Shaneyfelt, Terrence M. ;

Smaldone, Marc C. ;

Sonn, Geoffrey ;

Sprenkle, Preston ;

Vickers, Andrew J. ;

Wake, Robert ;

Shead, Dorothy A. ;

Freedman-Cass, Deborah A. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (05) :509-519

[6] Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer [J].

Castro, Elena ;

Goh, Chee ;

Leongamornlert, Daniel ;

Saunders, Ed ;

Tymrakiewicz, Malgorzata ;

Dadaev, Tokhir ;

Govindasami, Koveela ;

Guy, Michelle ;

Ellis, Steve ;

Frost, Debra ;

Bancroft, Elizabeth ;

Cole, Trevor ;

Tischkowitz, Marc ;

Kennedy, M. John ;

Eason, Jacqueline ;

Brewer, Carole ;

Evans, D. Gareth ;

Davidson, Rosemarie ;

Eccles, Diana ;

Porteous, Mary E. ;

Douglas, Fiona ;

Adlard, Julian ;

Donaldson, Alan ;

Antoniou, Antonis C. ;

Kote-Jarai, Zsofia ;

Easton, Douglas F. ;

Olmos, David ;

Eeles, Rosalind .

EUROPEAN UROLOGY, 2015, 68 (02) :186-193

[7] Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer [J].

Castro, Elena ;

Goh, Chee ;

Olmos, David ;

Saunders, Ed ;

Leongamornlert, Daniel ;

Tymrakiewicz, Malgorzata ;

Mahmud, Nadiya ;

Dadaev, Tokhir ;

Govindasami, Koveela ;

Guy, Michelle ;

Sawyer, Emma ;

Wilkinson, Rosemary ;

Ardern-Jones, Audrey ;

Ellis, Steve ;

Frost, Debra ;

Peock, Susan ;

Evans, D. Gareth ;

Tischkowitz, Marc ;

Cole, Trevor ;

Davidson, Rosemarie ;

Eccles, Diana ;

Brewer, Carole ;

Douglas, Fiona ;

Porteous, Mary E. ;

Donaldson, Alan ;

Dorkins, Huw ;

Izatt, Louise ;

Cook, Jackie ;

Hodgson, Shirley ;

Kennedy, M. John ;

Side, Lucy E. ;

Eason, Jacqueline ;

Murray, Alex ;

Antoniou, Antonis C. ;

Easton, Douglas F. ;

Kote-Jarai, Zsofia ;

Eeles, Rosalind .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (14) :1748-+

[8] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis [J].

Edwards, S. M. ;

Evans, D. G. R. ;

Hope, Q. ;

Norman, A. R. ;

Barbachano, Y. ;

Bullock, S. ;

Kote-Jarai, Z. ;

Meitz, J. ;

Falconer, A. ;

Osin, P. ;

Fisher, C. ;

Guy, M. ;

Jhavar, S. G. ;

Hall, A. L. ;

O'Brien, L. T. ;

Gehr-Swain, B. N. ;

Wilkinson, R. A. ;

Forrest, M. S. ;

Dearnaley, D. P. ;

Ardern-Jones, A. T. ;

Page, E. C. ;

Easton, D. F. ;

Eeles, R. A. .

BRITISH JOURNAL OF CANCER, 2010, 103 (06) :918-924

[9] Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene [J].

Edwards, SM ;

Kote-Jarai, Z ;

Meitz, J ;

Hamoudi, R ;

Hope, Q ;

Osin, P ;

Jackson, R ;

Southgate, C ;

Singh, R ;

Falconer, A ;

Dearnaley, DP ;

Ardern-Jones, A ;

Murkin, A ;

Dowe, A ;

Kelly, J ;

Williams, S ;

Oram, R ;

Stevens, M ;

Teare, DM ;

Ponder, BAJ ;

Gayther, SA ;

Easton, DF ;

Eeles, RA .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (01) :1-12

[10] Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer [J].

Gallagher, David J. ;

Gaudet, Mia M. ;

Pal, Prodipto ;

Kirchhoff, Tomas ;

Balistreri, Lisa ;

Vora, Kinjal ;

Bhatia, Jasmine ;

Stadler, Zsofia ;

Fine, Samson W. ;

Reuter, Victor ;

Zelefsky, Michael ;

Morris, Michael J. ;

Scher, Howard I. ;

Klein, Robert J. ;

Norton, Larry ;

Eastham, James A. ;

Scardino, Peter T. ;

Robson, Mark E. ;

Offit, Kenneth .

CLINICAL CANCER RESEARCH, 2010, 16 (07) :2115-2121

← 1 2 3 4 →